146
Federal Regulations. Title 21. Food and drugs. Vol. 4. Parts 200 to 299
.
Washington, DC, United States Government Printing Office, 2000:6–7.
13. Department of Health and Human Services, Food and Drug Administration.
Section 211.132. Tamper-evident packaging requirements for over-the-
counter (OTC) human drug products. In:
U.S. Code of Federal Regulations.
Title 21. Food and drugs. Vol. 4. Parts 200 to 299
. Washington, DC, United
States Government Printing Office, 2000:125–126.
14. Department of Health and Human Services, Food and Drug Administration.
Tamper-resistant packaging requirements for certain over-the-counter (OTC)
human drug products
. Washington, DC, United States Government Printing
Office, 1992 (FDA Compliance Policy Guide, 7132a.17).
15. Department of Health and Human Services, Food and Drug Administration.
Part 1700. Poison-Prevention Act of 1970 Regulations. In:
U.S. Code of
Federal Regulations. Title 16. Commercial practices. Chapter 2. Consumer
Product Safety Commission
. Washington, DC, United States Government
Printing Office, 1999:690–705.
16.
Child-resistant packaging — requirements and testing procedures for
reclosable packages. International Standard ISO 8317
. Geneva,
International Organization for Standardization, 1989.
17.
Specifications for packagings resistant to opening by children. British
Standard BS 6652
. London, British Standards Institution, 1985.
18.
Packaging — child-resistant packages — requirements, testing procedures,
non-reclosable packages for pharmaceutical products. DIN 55559
. Berlin,
German Standardization Institute, 1998.
19.
Packaging — child-resistant packaging — requirements and testing
procedures for non-reclosable packages for pharmaceutical products.
European Protocol prEN862
. Brussels, European Committee for
Standardization, 2000.
20. Sampling procedure for industrially manufactured pharmaceuticals. In:
WHO
Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-
first report
. Geneva, World Health Organization, 1990, Annex 2 (WHO
Technical Report Series, No. 790).
21. Plastic primary packaging materials. In:
The rules governing medicinal
products in the European Union. Vol. 3. Guidelines on the quality, safety
and efficacy of medicinal products for human use
. Brussels, European
Commission, 1998:75–82.
22.
WHO Expert Committee on Specifications for Pharmaceutical Preparations.
Twenty-fifth report
. Geneva, World Health Organization, 1975 (WHO
Technical Report Series, No. 567).
23. Council Directive 93/39/EEC of 14 June 1993 amending Directives 65/65/
EEC, 75/318/EEC and 75/319/EEC in respect of medicinal products.
Official
Journal of the European Communities
, 1993, 214:22–30.
24. Matters relating to the replacement of CFCs in medicinal products (3BR2a).
In:
The rules governing medicinal products in the European Union. Vol. 3B.
Safety, environment and information
. Brussels, European Commission, 1998.
25.
Assessment of potential risk to the environment posed by medicinal
products. European Directive No. 5504/94
. London, Medicines Control
Agency, 1994.